Brief: Senti Bio Posts Q4 Net Loss Of $18.2 Mln

Senti Biosciences Holdings

22/03/2023 21:14

March 22 (Reuters) - Senti Biosciences Inc  SNTI.O :
    * SENTI BIO REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND REVIEWS RECENT HIGHLIGHTS
    * NET LOSS WAS $18.2 MILLION, OR $0.42 PER BASIC AND DILUTED
SHARE, FOR QUARTER ENDED DECEMBER 31, 2022
    * CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS OF
$98.6
MILLION AS OF DECEMBER 31, 2022
    * CONTINUE TO EXPECT CASH RUNWAY THROUGH AT LEAST 1Q 2024
    * Q4 EARNINGS PER SHARE VIEW $-0.44 -- REFINITIV IBES DATA

Source: (https://bit.ly/3JZOu4Z)
Further company coverage:  SNTI.O 

 ((Reuters.Briefs@thomsonreuters.com;))